FDA Strengthens Warnings on Two Diabetes Drugs (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
Two drugs used to treat type 2 diabetes — canagliflozin and dapagliflozin — are associated with an increased risk for acute kidney injury, cautions the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Canagliflozin | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Invokana | Primary Care | Urology & Nephrology | Warnings